pyrroles has been researched along with Hepatitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alegret, M; Ađalsteisson, GS; Laguna, JC; Merlos, M; Rebollo, A; Roglans, N; Vilà, L | 1 |
| Hassanian, MA; Samy, W | 1 |
| DOWDLE, EB; EALES, L; SAUNDERS, SJ; SWEENEY, GD | 1 |
| Adim, SB; Dolar, E; Gulten, M; Gurel, S; Kiyici, M; Memik, F; Nak, SG; Savci, G; Yerci, O | 1 |
| Georgescu, EF; Georgescu, M | 1 |
| Gao, Y; Ge, GY; Jia, YJ; Jiang, MN; Song, LX | 1 |
| Mandó, OG; Ridruejo, E | 1 |
| Iwanow, ED | 1 |
3 trial(s) available for pyrroles and Hepatitis
| Article | Year |
|---|---|
Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Topics: Adult; Alanine Transaminase; Anticholesteremic Agents; Aryldialkylphosphatase; Aspartate Aminotransferases; Atorvastatin; Cholesterol; Cross-Sectional Studies; Disease Progression; Fatty Liver; Female; Glutathione Peroxidase; Hepatitis; Heptanoic Acids; Humans; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Pyrroles; Risk Factors; Triglycerides | 2011 |
Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Fatty Liver; Female; Hepatitis; Heptanoic Acids; Humans; Male; Middle Aged; Prospective Studies; Pyrroles; Ursodeoxycholic Acid | 2003 |
Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
Topics: Adult; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cholagogues and Choleretics; Fatty Liver; Female; Hematologic Agents; Hepatitis; Heptanoic Acids; Humans; Losartan; Male; Middle Aged; Pentoxifylline; Pyrroles; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
5 other study(ies) available for pyrroles and Hepatitis
| Article | Year |
|---|---|
Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
Topics: Animals; Atorvastatin; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cyclic AMP-Dependent Protein Kinases; Dietary Carbohydrates; Disease Models, Animal; Down-Regulation; Fatty Acids; Fatty Liver; Fructokinases; Fructose; Gene Expression Regulation; Hepatitis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; I-kappa B Proteins; Inflammation Mediators; Lipid Metabolism; Liver; Male; Metallothionein; Necrosis; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Phosphorylation; Pyrroles; Rats; Rats, Sprague-Dawley; Triglycerides | 2011 |
EFFECTS OF CHLOROQUINE ON PATIENTS WITH CUTANEOUS PORPHYRIA OF THE "SYMPTOMATIC" TYPE.
Topics: Amino Acids; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Chloroquine; Classification; Clinical Enzyme Tests; Fluids and Secretions; Glucosephosphate Dehydrogenase Deficiency; Glucosephosphates; Hepatitis; Humans; Levulinic Acids; Liver; Metabolism; Pathology; Porphyrias; Porphyrins; Pyrroles; Toxicology; Urine | 1965 |
Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
Topics: Acute-Phase Proteins; Alanine Transaminase; Animals; Atorvastatin; Carrier Proteins; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drugs, Chinese Herbal; Endotoxins; Fatty Liver; Hepatitis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Interleukin-1beta; Lipids; Lipopolysaccharide Receptors; Liver; Lymphocyte Antigen 96; Male; Membrane Glycoproteins; NF-kappa B; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; RNA, Messenger; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2008 |
Acute cholestatic hepatitis after reinitiating treatment with atorvastatin.
Topics: Acute Disease; Aged; Atorvastatin; Cholestasis; Hepatitis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles | 2002 |
[The role of delta-aminolevulinicacid-dehydrase (ALA-D) in the erythrocytes in the study of porphyrin biosynthesis].
Topics: Erythrocytes; Hepatitis; Hepatolenticular Degeneration; Humans; Hydro-Lyases; Kidney Diseases; Lead Poisoning; Levulinic Acids; Liver Cirrhosis; Nephritis; Porphyrias; Porphyrins; Pyelonephritis; Pyrroles | 1968 |